Pseudomonas aeruginosa bacteraemia in patients with hematologic malignancies: risk factors, treatment and outcome-Reference-Cited by-同舟云学术

Pseudomonas aeruginosa bacteraemia in patients with hematologic malignancies: risk factors, treatment and outcome

Published:2017-08 Issue:4 Volume:88 Page:335-341
ISSN:0732-8893
Container-title:Diagnostic Microbiology and Infectious Disease
language:en
Short-container-title:Diagnostic Microbiology and Infectious Disease

Author:

Tofas Polydoros,Samarkos Michael,Piperaki Evangelia-Theophano,Kosmidis Christos,Triantafyllopoulou Ioanna-Dionysia,Kotsopoulou Maria,Pantazatou Aggeliki,Perlorentzou Stavroula,Poulli Anastasia,Vagia Maria,Daikos George L.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference40 articles.

1. Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European conference on infections in leukemia (ECIL-4, 2011);Averbuch;Haematologica,2013

2. Advances in the management of Pseudomonas Aeruginosa infections in cancer patients;Bodey;Eur J Cancer,1973

3. Fluoroquinolones, antimicrobial resistance and neutropenic cancer patients;Bow;Curr Opin Infect Dis,2011

4. P. aeruginosa Bloodstream infections among hematological patients: an old or new question?;Cattaneo;Ann Hematol,2012

5. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation;Charlson;J Chronic Dis,1987

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of multidrug resistance on outcomes in hematologic cancer patients with bacterial bloodstream infections;Scientific Reports;2024-07-07

2. Risk factors and mortality of carbapenem-resistant Pseudomonas aeruginosa bloodstream infection in haematology department: A 10-year retrospective study;Journal of Global Antimicrobial Resistance;2024-06

3. Pseudomonas aeruginosa Bloodstream Infections Presenting with Septic Shock in Neutropenic Cancer Patients: Impact of Empirical Antibiotic Therapy;Microorganisms;2024-03-30

4. Effectiveness and Safety of Colistimethate Sodium Used in the Treatment of Neutropenic Blood Cancer Patients Infected with Multidrug-Resistant Pseudomonas aeruginosa;Arabian Journal for Science and Engineering;2024-03-06

5. Extensively drug-resistant Pseudomonas aeruginosa: clinical features and treatment with ceftazidime/avibactam and ceftolozane/tazobactam in a tertiary care university hospital center in Portugal – A cross-sectional and retrospective observational study;Frontiers in Microbiology;2024-02-13